Gong SX - Search Results

1

Microglia-associated neuroinflammation is a potential therapeutic target for ischemic stroke.

Zhang W, Tian T, Gong SX, Huang WQ, Zhou QY, Wang AP, Tian Y. Zhang W, et al. Among authors: gong sx. Neural Regen Res. 2021 Jan;16(1):6-11. doi: 10.4103/1673-5374.286954. Neural Regen Res. 2021. PMID: 32788440 Free PMC article.

2

miR-100 suppresses mTOR signaling in hypoxia-induced pulmonary hypertension in rats.

Wang AP, Li XH, Gong SX, Li WQ, Hu CP, Zhang Z, Li YJ. Wang AP, et al. Among authors: gong sx. Eur J Pharmacol. 2015 Oct 15;765:565-73. doi: 10.1016/j.ejphar.2015.09.031. Epub 2015 Sep 25. Eur J Pharmacol. 2015. PMID: 26409044

3

eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.

Guo L, Li Y, Tian Y, Gong S, Chen X, Peng T, Wang A, Jiang Z. Guo L, et al. Drug Des Devel Ther. 2019 Aug 13;13:2799-2809. doi: 10.2147/DDDT.S213817. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31496656 Free PMC article.

4

Pulmonary Artery Smooth Muscle Cell Senescence Promotes the Proliferation of PASMCs by Paracrine IL-6 in Hypoxia-Induced Pulmonary Hypertension.

Wang AP, Yang F, Tian Y, Su JH, Gu Q, Chen W, Gong SX, Ma XF, Qin XP, Jiang ZS. Wang AP, et al. Among authors: gong sx. Front Physiol. 2021 Apr 7;12:656139. doi: 10.3389/fphys.2021.656139. eCollection 2021. Front Physiol. 2021. PMID: 33897463 Free PMC article.

5

Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases.

Su JH, Luo MY, Liang N, Gong SX, Chen W, Huang WQ, Tian Y, Wang AP. Su JH, et al. Among authors: gong sx. Front Pharmacol. 2021 Aug 24;12:745061. doi: 10.3389/fphar.2021.745061. eCollection 2021. Front Pharmacol. 2021. PMID: 34504432 Free PMC article. Review.

6

Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases.

Luo MY, Su JH, Gong SX, Liang N, Huang WQ, Chen W, Wang AP, Tian Y. Luo MY, et al. Among authors: gong sx. Front Cell Dev Biol. 2021 Nov 11;9:733908. doi: 10.3389/fcell.2021.733908. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34858973 Free PMC article. Review.

7

Mammalian Target of Rapamycin as the Therapeutic Target of Vascular Proliferative Diseases: Past, Present, and Future.

Huang WQ, Zou Y, Tian Y, Ma XF, Zhou QY, Li ZY, Gong SX, Wang AP. Huang WQ, et al. Among authors: gong sx. J Cardiovasc Pharmacol. 2022 Apr 1;79(4):444-455. doi: 10.1097/FJC.0000000000001208. J Cardiovasc Pharmacol. 2022. PMID: 34983907

8

Targeting Vascular Smooth Muscle Cell Senescence: A Novel Strategy for Vascular Diseases.

Lin MJ, Hu SL, Tian Y, Zhang J, Liang N, Sun R, Gong SX, Wang AP. Lin MJ, et al. Among authors: gong sx. J Cardiovasc Transl Res. 2023 Oct;16(5):1010-1020. doi: 10.1007/s12265-023-10377-7. Epub 2023 Mar 27. J Cardiovasc Transl Res. 2023. PMID: 36973566 Review.

9

Critical miRNAs in regulating pulmonary hypertension: A focus on Signaling pathways and therapeutic Targets.

Wang D, Luo MY, Tian Y, Zhang J, Liang N, Li NP, Gong SX, Wang AP. Wang D, et al. Among authors: gong sx. Anal Biochem. 2023 Aug 15;675:115228. doi: 10.1016/j.ab.2023.115228. Epub 2023 Jun 30. Anal Biochem. 2023. PMID: 37393975 Review.

10

Upregulation of eIF2α by m⁶A modification accelerates the proliferation of pulmonary artery smooth muscle cells in MCT-induced pulmonary arterial hypertension rats.

Zhang J, Huang WQ, Zhang YR, Liang N, Li NP, Tan GK, Gong SX, Wang AP. Zhang J, et al. Among authors: gong sx. J Cardiovasc Transl Res. 2024 Jun;17(3):598-608. doi: 10.1007/s12265-023-10458-7. Epub 2023 Nov 16. J Cardiovasc Transl Res. 2024. PMID: 37973667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters